Find out why Aplenzin XR is so hard to find at pharmacies in 2026, what's causing supply issues, and what you can do to fill your prescription.
You hand your prescription to the pharmacy tech, wait 15 minutes, and hear the words no one wants to hear: "We don't have Aplenzin in stock." If this has happened to you — maybe more than once — you're far from alone. Aplenzin XR (Bupropion Hydrobromide) is one of the most difficult brand-name antidepressants to track down at U.S. pharmacies in 2026.
This isn't your fault, and it doesn't mean your medication doesn't exist. There are specific reasons why Aplenzin XR is so hard to find, and there are steps you can take right now to get your prescription filled. Let's break it all down.
Aplenzin XR is the brand name for Bupropion Hydrobromide, an extended-release antidepressant made by Bausch Health. It's FDA-approved to treat major depressive disorder (MDD) and seasonal affective disorder (SAD).
Aplenzin belongs to a class of medications called norepinephrine-dopamine reuptake inhibitors (NDRIs). Unlike many other antidepressants, it works on dopamine and norepinephrine — not serotonin — which is why some patients prefer it. It's known for having a lower risk of weight gain and sexual side effects compared to SSRIs.
Aplenzin comes in three strengths: 174 mg, 348 mg, and 522 mg extended-release tablets, taken once daily in the morning. If you'd like a deeper dive, check out our guide on what Aplenzin XR is, its uses, and dosage.
There isn't one single reason Aplenzin XR is difficult to locate. It's a combination of factors that make this medication scarce at many pharmacies.
As of early 2026, there is no FDA-approved generic version of Aplenzin (Bupropion Hydrobromide). While generic Bupropion Hydrochloride (the active ingredient in Wellbutrin XL) is widely available and costs as little as $15-$40 per month, Aplenzin uses a different salt form — Bupropion Hydrobromide — and no generic manufacturer has brought a copy to market yet. The earliest estimated date for a generic is mid-2026.
When only one company makes a drug, any supply hiccup can leave pharmacies empty-handed.
Aplenzin XR costs over $3,200 per month at retail. Most patients with depression are prescribed generic Bupropion HCl instead because insurance companies prefer it and it costs a fraction of the price. This means most pharmacies simply don't keep Aplenzin on the shelf — there isn't enough demand to justify tying up that much inventory in one product.
Chain pharmacies in particular are less likely to carry Aplenzin because their ordering systems are driven by local demand data.
Many insurance plans place Aplenzin on a non-preferred brand tier (Tier 3 or higher) and require prior authorization or step therapy — meaning you have to try generic Bupropion HCl first and fail before they'll approve Aplenzin. This keeps prescription volume low, which in turn keeps pharmacy stocking low.
The generic Bupropion HCl market experienced significant supply disruptions in 2023-2024 due to increased demand and manufacturing issues. When generic versions are hard to find, some patients and prescribers turn to Aplenzin as an alternative — putting even more pressure on an already limited supply.
The good news: with the right approach, most patients can still get their Aplenzin XR filled. Here's what to try.
Medfinder lets you search for pharmacies that currently have Aplenzin XR in stock near your location. Instead of calling pharmacy after pharmacy, you get real-time availability information in one place.
Independent pharmacies often have more flexibility in what they stock and can order specialty medications faster than chain pharmacies. Compounding pharmacies and specialty pharmacies that focus on mental health medications may also be good options.
The Aplenzin Savings & Access Program from Bausch Health may offer free home delivery of the medication for eligible patients. This can bypass the pharmacy stocking problem entirely.
If Aplenzin XR is truly unavailable, your doctor may consider switching you to generic Bupropion HCl XL (Wellbutrin XL), which is bioequivalent. The dose conversion is straightforward: 174 mg Aplenzin = 150 mg Wellbutrin XL, 348 mg = 300 mg, and 522 mg = 450 mg. For more options, see our post on alternatives to Aplenzin XR.
Finding Aplenzin XR in 2026 can feel like a scavenger hunt, but understanding why it's scarce makes the search easier. It's not a nationwide shortage in the traditional sense — it's a combination of limited manufacturing, low pharmacy stocking, and insurance hurdles that make it hard to fill.
Start with Medfinder to locate pharmacies with stock near you, explore the manufacturer's savings program, and keep your prescriber in the loop. You have more options than you might think.
For more tips on tracking down your medication, read our guide on how to find Aplenzin XR in stock near you.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
